Key words below "leading Institution" and "Radiologists"
I have a difficult time seeing this as Abbott.
"According to the researcher who discovered the RECAF marker, Ricardo Moro-Vidal, M.D., CEO and president, the company is gearing up to begin a clinical trial with a leading institution to determine if a blood test can help radiologists better anticipate if a lesion is benign or malignant.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.